Mid-Year Report

ML STRATEGIES, LLC for MGI PHARMA INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1082 FDA Revitalization Act

LobbyistCovered position, as disclosed
MARK BUSE N/A
KENNETH CONNOLLY STAFF DIRECTOR SENATE EPW COMMITTE
STEVEN IRIZARRY N/A
DAVID LEITER N/A
PATRICK D MARA N/A
ROBERT NEAL MARTIN N/A
JEREMY RABINOVITZ CHIEF OF STAFF - CONGRESSWOMAN LOIS CAPPS

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1082 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.